Roth Capital Downgrades Aeolus Pharmaceuticals (AOLS) to Neutral
Tweet Send to a FriendGet Alerts AOLS Hot Sheet
Price: $0.39 -2.5%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade AOLS Now!
Roth Capital downgraded Aeolus Pharmaceuticals (OTCBB: AOLS) from Buy to Neutral with a price target of $1.00 (from $3.00).
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday, with a 52 week range of $0.21-$0.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday, with a 52 week range of $0.21-$0.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- HSBC Downgrades Carnival Corporation (CCL) to Neutral
- Goldman Sachs Downgrades Aixtron (AIXG) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
